Back

Controversies in contemporary drug therapy for heart failure - discussion

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Controversies in contemporary drug therapy for heart failure Cardiovascular Pharmacotherapy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

3 More presentations in this session

Presentation thumbnail
Digitoxin and digoxin: standard therapy for HFrEF?
Professor U. Bavendiek (Hannover, DE)
Slides Video
Presentation thumbnail
Verigicuat: standard therapy for HFrEF?
Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Slides Video
Presentation thumbnail
Non-steroidal mineralocorticoid receptor antagonists (MRAs): standard therapy for HFpEF?
Doctor A. Ruwald (Copenhagen, DK)
Slides Video

Access the full session

Session thumbnail
Controversies in contemporary drug therapy for heart failure
Video

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Controversies in contemporary drug therapy for heart failure
thumbnail
Congress Session
The floor is yours: bring your questions on heart failure. 'Heart's failing secrets unveiled: thy burning queries expertly resolved'
thumbnail
Congress Session
Innovations in heart failure management

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources